Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02184572
Brief Title: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

First Submitted : July 3, 2014
First Submitted that Met QC Criteria : July 3, 2014
First Posted : July 9, 2014 (Estimate)

Results First Submitted : December 27, 2016
Results First Submitted that Met QC Criteria : June 1, 2018
Results First Posted : July 3, 2018

Certification/Extension First Submitted : September 22, 2016
Certification/Extension First Submitted that Met QC Criteria : September 22, 2016
Certification/Extension First Posted : October 19, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 1, 2018
Last Update Posted : July 3, 2018